Experience of brentuximab vedotin in relapsed/refractory Hodgkin lymphoma and relapsed/refractory systemic anaplastic large-cell lymphoma in the Named Patient Program: Review of the literature
- Resource Type
- Review Article
- Source
- In
Critical Reviews in Oncology / Hematology September 2015 95(3):359-369 - Subject
- Language
- ISSN
- 1040-8428